BIIB028
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB028, covering 2017-01-09 to 2017-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Administration of BIIB028 to Subjects With Solid Tumors [Phase 1]